UBS analyst Trung Huynh raised the firm’s price target on AbbVie (ABBV) to $220 from $195 and keeps a Neutral rating on the shares. The firm updated its model following the Q3 earnings report.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV: